27th February, 2025 In a major step towards making essential medicines more affordable, the National Pharmaceutical Pricing Authority (NPPA) has directed pharmaceutical manufacturers and marketers to reduce the Maximum Retail Price (MRP) of specific drugs that recently received customs duty…
Recent Post
- Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls
- CDSCO Restricts IVF Supplies to Registered ART Centres
- CDSCO Issues Clarity on New Drugs, DC Granules & MR Pellets Licensing
- Centre Bans 16 Fixed Dose Combinations Under Section 26A of Drugs & Cosmetics Act
- India Cracks Down on Chloramphenicol & Nitrofurans in Food Producing Animals
